These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 2361659

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.
    Brun A, Englund E.
    Ann Neurol; 1986 Mar; 19(3):253-62. PubMed ID: 3963770
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia.
    Hirono N, Yasuda M, Tanimukai S, Kitagaki H, Mori E.
    Stroke; 2000 Jun; 31(6):1263-8. PubMed ID: 10835442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia.
    Erkinjuntti T, Benavente O, Eliasziw M, Munoz DG, Sulkava R, Haltia M, Hachinski V.
    Arch Neurol; 1996 Apr; 53(4):325-32. PubMed ID: 8929154
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neurochemical changes in white matter. Aged human brain and Alzheimer's disease.
    Malone MJ, Szoke MC.
    Arch Neurol; 1985 Nov; 42(11):1063-6. PubMed ID: 4051835
    [Abstract] [Full Text] [Related]

  • 11. Correlations between histopathologic white matter changes and proton MR relaxation times in dementia.
    Englund E, Brun A, Persson B.
    Alzheimer Dis Assoc Disord; 1987 Nov; 1(3):156-70. PubMed ID: 3453747
    [Abstract] [Full Text] [Related]

  • 12. Decreased myelin lipids in Alzheimer's disease and vascular dementia.
    Wallin A, Gottfries CG, Karlsson I, Svennerholm L.
    Acta Neurol Scand; 1989 Oct; 80(4):319-23. PubMed ID: 2816288
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cerebral grey and white matter changes in mild cognitive impairment and Alzheimer's disease.
    Luckhaus C.
    Eur J Neurol; 2009 Apr; 16(4):438-9. PubMed ID: 19348619
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Cerebral lacunae: still under debate].
    Derouesné C, Poirier J.
    Rev Neurol (Paris); 1999 Oct; 155(10):823-31. PubMed ID: 10546297
    [Abstract] [Full Text] [Related]

  • 17. A case of Alzheimer's disease with extensive focal white matter changes.
    Zahner B, Lang CJ, Engelhardt A, Thierauf P, Neundörfer B.
    Dementia; 1995 Oct; 6(5):294-300. PubMed ID: 8528377
    [Abstract] [Full Text] [Related]

  • 18. White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes.
    Nasrabady SE, Rizvi B, Goldman JE, Brickman AM.
    Acta Neuropathol Commun; 2018 Mar 02; 6(1):22. PubMed ID: 29499767
    [Abstract] [Full Text] [Related]

  • 19. White matter lesions, dementia, and ischemic axonopathy.
    Ball MJ.
    Alzheimer Dis Assoc Disord; 2003 Mar 02; 17(1):55. PubMed ID: 12621320
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.